We demonstrated that PVSO alleviated fatigue-like behavior in two fatigue models, and its improvement of breast-cancer related fatigue may be mediated by attenuating the hypothalamic inflammation induced by infiltration of tumor, and subsequent restoring corticotropin-releasing hormone (CRH) and cortisol levels. This evidence concerns the gene CRH and neoplasm.